Category: P
-
Permax
Former brand name for the withdrawn antiparkinsonian Drug pergolide.
-
Periaqueductal gray area
A cluster of neurons lying in the thalamus and pons. It contains endorphin-producing neurons and opioid receptor sites and thus can affect the sensation of pain.
-
Periactin
Brand name (now discontinued) for cyproheptadine.
-
Pergolide
A dopamine agonist used as an adjunctive treatment with carbidopa-levodopa therapy in the management of signs and symptoms of parkinson’s disease. Pergolide (including all generic and brand [permax] products) was withdrawn from the u.s. Market in 2007 after several published studies revealed a link between the drug and increased rates of valvular dysfunction. An antidyskinetic…
-
Perdida del alma
A culture-specific syndrome.
-
Pentazocine
An opioid partial agonist used to treat moderate to severe pain. Marketed under the brand name talwin. A narcotic analgesic. Analgesic used to treat moderate to severe pain. Adverse effects include nausea, dizziness, gastrointestinal upsets, and, in high doses, respiratory and circulatory depression; withdrawal symptoms after prolonged use may also occur. A potent analgesic drug…
-
Penis envy
In psychoanalytic theory, envy by the female child of the male child’s genitals and presumably associated powers or privileges. The desire of the female for male sex organs or status, Electra complex; phallic stage. In psychoanalysis, the female’s desire to have a penis.
-
Pemoline
A stimulant medication used in the treatment of attention-deficit/hyperactivity disorder (ADHD). Pemoline (including all generic and brand [cylert] products) was withdrawn from the u.s. Market in 2005 because of its association with life-threatening liver failure. A stimulant used in ADD with hyperactivity. A drug that stimulates the central nervous system. Pemoline (Cylert) is used to…
-
Pelizaeus-merzbacher disease
An inherited condition that rarely affects females and involves the brain and the central nervous system (CNS). This disease is one of a group of genetic disorders called leukodystrophies. Pelizaeus-Merzbacher disease is caused by an inability to form myelin. As a result, individuals with this condition have impaired intellectual functions, such as language and memory,…
-
Peer review organization (PRO)
A system that determines the appropriateness and reasonableness of medical care under the medicare or medicaid programs. An organization set up as a part of the prospective payment system (PPS) to carry out certain review functions under contract from the Health Care Financing Administration (HCFA). PROs are external to the hospital; some were formerly Professional Standards…